Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Infections News
Hooked on ID with Monica V. Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP
My journey in infectious diseases started out with an intense hatred and utter confusion.
CDC: ‘Consider shigellosis’ for acute diarrhea amid surge in drug resistant cases
The CDC issued a health advisory alerting clinicians to a spike in extensively drug-resistant shigellosis in the United States, urging them to consider this infection in cases of acute diarrhea, especially among higher risk patients.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: The challenges of curing hepatitis B
SEATTLE — The effort to find a cure for hepatitis B faces steep challenges, Anna Suk-Fong Lok, MD, told Healio after her plenary presentation at the Conference for Retroviruses and Opportunistic Infections.
‘Negative Fauci effect’? ID reckons with disappointing Match Day
As the COVID-19 pandemic grew, so did the feeling that the field of ID might begin to attract more physicians, drawn by the important and rewarding work that was so suddenly in the public eye.
Hooked on ID with J. Glenn Morris Jr., MD, MPH&TM
I grew up in Bangkok, where I saw first-hand the impact of cholera, dengue, malaria and other tropical diseases — and experienced the early waves of the seventh pandemic of cholera.
Do ID physicians have a good quality of life?
Physicians have cited overwork and burnout as contributing factors making it difficult to recruit physicians for a career in infectious diseases.
Study outlines characteristics of invasive E. coli disease by setting, age, outcome
A recent study published in Open Forum Infectious Diseases outlined the clinical characteristics of invasive Escherichia coli disease by stratifying cases by acquisition setting, patient age and infection outcome.
Vonoprazan stalled for esophagitis, H. pylori as FDA cites nitrosamine impurity concerns
The FDA has rejected Phathom Pharmaceutical’s vonoprazan new drug application for erosive esophagitis, as well as its post-approval supplement for Helicobacter pylori, due to the presence of nitrosamine impurities.
Bezlotoxumab, fecal microbiota transplant similarly effective in preventing recurrent CDI
Bezlotoxumab and fecal microbiota transplantation were similarly effective at preventing both early and late recurrent Clostridioides difficile infection, according to a study published in Open Forum Infectious Diseases.
Probiotic safely reduces S. aureus colonization in human trial
A probiotic safely reduced Staphylococcus aureus colonization in a phase 2 human trial without harming other gut microbiota, suggesting a potential approach to preventing infection without using antibiotics.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read